Leerink Partners analyst Michael Cherny reiterated a Market Perform rating on CVS Health (NYSE: CVS).The analyst comments "Bottom Line: Following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE